abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2014 to Q4 2025

Type / Class
Equity / Common Shares, $0.01 par value
Symbol
HQL on NYSE
Shares outstanding
29,596,439
Price per share
$16.69
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
9,135,004
Total reported value
$141,447,637
% of total 13F portfolios
0%
Share change
-47,626
Value change
-$612,085
Number of holders
81
Price from insider filings
$16.69
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FIRST TRUST PORTFOLIOS LP 6.3% $20,975,246 1,827,112 First Trust Portfolios L.P. 31 Mar 2025
Saba Capital Management, L.P. 5.7% -15% $28,155,980 -$5,266,012 1,686,997 -16% Saba Capital Management, L.P. 09 Feb 2026

As of 30 Sep 2025, 81 institutional investors reported holding 9,135,004 shares of abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL). This represents 31% of the company’s total 29,596,439 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) together control 29% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Saba Capital Management, L.P. 8.7% 2,586,652 -14% 1.3% $40,118,973
MORGAN STANLEY 2.9% 870,658 +14% 0% $13,503,918
Penserra Capital Management LLC 2.7% 794,138 +3.2% 0.15% $12,317,000
RAYMOND JAMES FINANCIAL INC 1.4% 423,031 +13% 0% $6,561,205
NEEDHAM INVESTMENT MANAGEMENT LLC 1.4% 403,364 +3% 0.44% $6,256,175
LPL Financial LLC 1.3% 374,059 +8.6% 0% $5,801,661
FLAGSHIP HARBOR ADVISORS, LLC 1.2% 357,124 +4.4% 0.24% $5,539,006
RIVERNORTH CAPITAL MANAGEMENT, LLC 1% 307,637 +34% 0.27% $4,771,450
Karpus Management, Inc. 1% 300,284 -30% 0.15% $4,657,405
Allspring Global Investments Holdings, LLC 0.8% 235,499 0% 0.01% $3,652,589
WOLVERINE ASSET MANAGEMENT LLC 0.73% 215,521 +51% 0.05% $3,342,730
AMERIPRISE FINANCIAL INC 0.71% 209,681 +24% 0% $3,253,941
Shaker Financial Services, LLC 0.67% 197,804 +537% 1.1% $3,067,941
Advisors Asset Management, Inc. 0.54% 159,156 -0.63% 0.04% $2,468,510
180 WEALTH ADVISORS, LLC 0.5% 149,258 +4.3% 0.28% $2,314,995
1607 Capital Partners, LLC 0.41% 122,170 -25% 0.14% $1,894,857
Thomas J. Herzfeld Advisors, Inc. 0.4% 116,937 0.62% $1,813,693
BANK OF AMERICA CORP /DE/ 0.38% 113,006 -22% 0% $1,752,726
World Investment Advisors 0.31% 92,866 0.03% $1,440,353
Janney Montgomery Scott LLC 0.28% 82,345 0% $1,277,000
ROYAL BANK OF CANADA 0.27% 79,231 -82% 0% $1,228,000
Formidable Asset Management, LLC 0.26% 76,193 +19% 0.15% $976,032
UHLMANN PRICE SECURITIES, LLC 0.25% 73,900 +20% 0.7% $1,146,158
BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC 0.22% 64,828 +2.9% 0.15% $1,005,482
Private Advisor Group, LLC 0.22% 63,688 +24% 0% $987,793

Institutional Holders of abrdn Life Sciences Investors - Common Shares, $0.01 par value (HQL) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 3,309,771 $55,379,041 -$712,608 $16.78 48
2025 Q3 9,135,004 $141,447,637 -$612,085 $15.51 81
2025 Q2 9,160,432 $117,354,763 +$3,718,133 $12.81 75
2025 Q1 8,871,741 $112,593,442 -$7,767,198 $12.69 82
2024 Q4 9,410,282 $123,499,638 -$6,086,141 $13.12 71
2024 Q3 9,806,530 $147,862,022 +$3,776,042 $15.08 73
2024 Q2 8,741,990 $123,956,719 +$7,652,552 $14.17 73
2024 Q1 9,097,862 $123,990,564 +$15,006,389 $13.63 79
2023 Q4 7,899,191 $106,393,598 +$23,510,111 $13.46 77
2023 Q3 5,732,506 $71,473,586 +$11,458,112 $12.47 77
2023 Q2 20,712 $280,434 -$299,086 $10.27 2
2023 Q1 5,187,056 $72,249,568 +$252,375 $13.93 77
2022 Q4 5,214,982 $74,159,302 +$13,460,478 $14.21 78
2022 Q3 4,243,446 $57,969,986 +$8,298,838 $13.66 57
2022 Q2 3,670,843 $52,260,963 +$389,994 $14.23 62
2022 Q1 3,659,471 $60,564,148 -$3,607,311 $16.54 61
2021 Q4 3,874,395 $74,397,923 -$4,346,438 $19.23 62
2021 Q3 4,079,012 $85,058,000 -$6,795,102 $20.80 61
2021 Q2 4,393,904 $94,225,459 -$7,767,122 $21.44 63
2021 Q1 4,759,098 $93,769,016 -$3,063,176 $19.71 59
2020 Q4 4,901,740 $96,913,930 +$4,277,096 $19.75 61
2020 Q3 4,667,693 $82,119,114 +$2,719,516 $17.58 56
2020 Q2 4,593,229 $82,470,887 +$2,221,252 $17.96 65
2020 Q1 4,249,560 $63,692,146 +$3,454,796 $14.98 63
2019 Q4 4,081,292 $71,163,712 +$10,109,144 $17.43 62
2019 Q3 3,065,002 $46,361,468 +$1,932,727 $15.10 55
2019 Q2 3,165,675 $53,305,158 -$107,688 $16.85 50
2019 Q1 3,197,807 $54,748,908 -$1,461,169 $17.13 51
2018 Q4 3,256,357 $49,207,495 +$630,272 $15.11 53
2018 Q3 3,151,994 $64,350,945 -$130,571 $20.42 52
2018 Q2 3,204,169 $60,229,278 -$51,307 $18.79 57
2018 Q1 2,527,451 $48,394,490 +$1,595,714 $19.21 53
2017 Q4 2,430,438 $47,770,863 +$3,274,459 $19.63 52
2017 Q3 2,039,619 $43,909,029 +$4,127,820 $21.48 49
2017 Q2 2,231,422 $46,549,000 +$7,299 $20.85 41
2017 Q1 2,270,439 $43,880,000 -$1,380,409 $19.39 38
2016 Q4 2,565,495 $43,758,000 +$3,771,221 $16.99 44
2016 Q3 2,171,425 $40,653,000 -$925,001 $18.73 41
2016 Q2 2,226,005 $38,335,000 -$3,677,887 $17.19 46
2016 Q1 1,716,815 $30,847,000 -$4,719,186 $17.94 41
2015 Q4 2,618,012 $61,825,000 +$3,683,007 $23.64 45
2015 Q3 2,464,520 $55,594,000 +$3,050,180 $22.51 40
2015 Q2 2,302,026 $64,978,792 +$5,330,707 $28.21 39
2015 Q1 2,111,601 $58,176,144 -$947,910 $27.57 38
2014 Q4 2,150,586 $53,522,700 +$51,462,337 $24.88 37
2014 Q3 2,881 $64,000 +$64,000 $22.15 2